Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Multi-site Study of Autologous Cord Blood Cells for Hypoxic (HIE)

NCT02612155 is registered in ClinicalTrials.gov with Michael Cotten as lead sponsor.

NCT NCT02612155
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02612155 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Multi-site Study of Autologous Cord Blood Cells for Hypoxic (HIE)
Lead sponsor
Michael Cotten
Phase
Phase 2
Overall status
Completed
Start date
March 30, 2017
Completion date
August 5, 2019
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

moderate or severe hypoxic-ischemic encephalopathy in newborns